Thus, given the importance of CHK2 and AR to the DDR and prostate cancer growth, a full understanding of the functional consequences of the CHK2–AR interaction is required, with the hope of possible clinical applications towards CRPC. This evidence concerns the gene AR and Familial prostate cancer.